Background: Current chemical-shift-encoded (CSE) MRI techniques for measuring hepatic proton density fat fraction (PDFF) are sensitive to motion artifacts. Purpose: Initial validation of a motion-robust 2D-sequential CSE-MRI technique for quantification of hepatic PDFF. Study Type: Phantom study and prospective in vivo cohort. Population: Fifty adult patients (27 women, 23 men, mean age 57.2 years). Field Strength/Sequence: 3D, 2D-interleaved, and 2D-sequential CSE-MRI acquisitions at 1.5T. Assessment: Three CSE-MRI techniques (3D, 2D-interleaved, 2D-sequential) were performed in a PDFF phantom and in vivo. Reference standards were 3D CSE-MRI PDFF measurements for the phantom study and single-voxel MR spectroscopy hepatic PDFF measurements (MRS-PDFF) in vivo. In vivo hepatic MRI-PDFF measurements were performed during a single breath-hold (BH) and free breathing (FB), and were repeated by a second reader for the FB 2D-sequential sequence to assess interreader variability. Statistical Tests: Correlation plots to validate the 2D-sequential CSE-MRI against the phantom and in vivo reference standards. Bland-Altman analysis of FB versus BH CSE-MRI acquisitions to evaluate robustness to motion. Bland-Altman analysis to assess interreader variability. Results: Phantom 2D-sequential CSE-MRI PDFF measurements demonstrated excellent agreement and correlation (R 2 > 0.99) with 3D CSE-MRI. In vivo, the mean (6SD) hepatic PDFF was 8.8 6 8.7% (range 0.6-28.5%). Compared with BH acquisitions, FB hepatic PDFF measurements demonstrated bias of 10.15% for 2D-sequential compared with 1 0.53% for 3D and 10.94% for 2D-interleaved. 95% limits of agreement (LOA) were narrower for 2D-sequential (60.99%), compared with 3D (63.72%) and 2D-interleaved (63.10%). All CSE-MRI techniques had excellent correlation with MRS (R 2 > 0.97). The FB 2D-sequential acquisition demonstrated little interreader variability, with mean bias of 10.07% and 95% LOA of 6 1.53%. Data Conclusion: This motion-robust 2D-sequential CSE-MRI can accurately measure hepatic PDFF during free breathing in a patient population with a range of PDFF values of 0.6-28.5%, permitting accurate quantification of liver fat content without the need for suspended respiration. Level of Evidence: 1 Technical Efficacy: Stage 2
changes in the form of nonalcoholic steatohepatitis (NASH) and ultimately cirrhosis and endstage liver disease. 4, 5 This same progression of disease also increases the risk of hepatocellular carcinoma in patients with NAFLD/NASH. 6 Historically, direct pathologic analysis of tissue obtained from liver biopsy was the only reliable method widely available to diagnose and quantify NAFLD. 7 Due to the invasiveness of this procedure, it is difficult to justify the risk and discomfort to the patient inherent in using liver biopsy to monitor liver fat content over time. Furthermore, random liver biopsy only samples a very small fraction of the liver parenchyma. Magnetic resonance spectroscopy (MRS) is another available method for determining liver fat content and can serve as a useful reference standard, 8 but only samples a small fraction of the liver parenchyma-similar to biopsy-but is generally limited in availability and requires complicated processing that may not be feasible in the clinical setting. Fortunately, chemical shift-encoded (CSE) MRI techniques have been developed that accurately and noninvasively measure liver proton density fat fraction (PDFF), a quantitative imaging biomarker of liver fat content. [9] [10] [11] [12] Current CSE-MRI techniques, which are based on multiecho spoiled gradient echo (SGRE) using either 3D or 2D sliceinterleaved acquisitions, are susceptible to motion-related artifacts. Unfortunately, these techniques require a prolonged breath-hold to avoid motion-related artifacts, which is often challenging for ill patients and children. In previous studies, respiratory-gating and navigator-based methods have been shown to enable accurate hepatic PDFF quantification without the need for suspending respiration. 13 Gated methods, however, require a longer scan time, and the resulting images still contain moderate residual motion artifact.
To address this issue, we describe below the use of a sequentially acquired 2D CSE-MRI technique that can be used to assess liver fat content during free breathing. This technique represents an improvement over predecessors in that it has an extremely short temporal footprint (1-2 sec/ slice), which essentially negates breathing motion without the need for respiratory gating. The purpose of this study was to demonstrate the feasibility and validity of this 2D-sequential CSE-MRI technique for motion-robust quantification of liver fat content.
Materials and Methods

Phantom Study
A PDFF phantom consisting of 11 cylindrical vials with varying peanut oil concentrations in an agar-based emulsion with nominal PDFF values of 0, 2.5%, 5%, 7.5%, 10%, 15%, 20%, 30%, 40%, 50%, and 100% was constructed as previously described. 14, 15 The phantom was scanned using three different CSE-MRI techniques (2D-sequential CSE-MRI, 2D-interleaved CSE-MRI, and 3D CSE-MRI) using acquisition parameters shown in Table 1 . 3D CSE-MRI was used as the reference standard for MRI-PDFF. 3D CSE-MRI has been previously validated in phantoms as an accurate biomarker of fat concentration.
14,15
Patient Population and In Vivo Study Design
This prospective observational study was approved by our Institutional Review Board and maintained full compliance with the Health Insurance Portability and Accountability Act (HIPAA). Signed informed consent was obtained from all study participants. Over 7 months (August 1, 2016 through February 28, 2017), adult patients undergoing clinically indicated diagnostic abdominal MRI were prospectively enrolled to undergo CSE-MRI to measure hepatic PDFF as an adjunct to the clinical scan. Patients were eligible for inclusion if they were 18 years of age or older and were undergoing an abdominal MRI protocol requiring the use of a phased-array torso coil. As the aim of this study was to demonstrate the general feasibility of 2D-sequential CSE-MRI for the quantification of hepatic PDFF during free breathing, there were no specifically defined exclusion criteria. Once enrolled, patients underwent acquisitions using three different CSE-MRI techniques (2D-sequential CSE-MRI, 2D-interleaved CSE-MRI, and 3D CSE-MRI) using acquisition parameters shown in Table 2 , each performed once during a single breath-hold (BH) and once during free breathing (FB), for a total of six CSE-MRI scans. Single-voxel MRS was also performed in the right lobe of the liver (Couinaud segment 6/7) using a stimulated echo acquisition mode (STEAM) technique as an independent reference measurement of hepatic PDFF for each patient. These six CSE-MRI acquisitions and one MRS acquisition resulted in a total of seven acquisitions per patient.
CSE-MRI Technique and PDFF Analysis
All phantom and human subject imaging was performed on a clinical 1.5T MRI system (MR450w v25.0, GE Healthcare, Waukesha, WI) using a 12-channel phased-array torso coil. Imaging was performed using investigational versions of a complex-based quantitative CSE-MRI method (IDEAL IQ, GE Healthcare) to quantify PDFF. This CSE-MRI method corrects or minimizes confounding factors that introduce error in PDFF measurement in conventional MRI, including T 1 -related bias, 16 noise bias, 16 R2* signal decay, 17 multifrequency interference effects of fat, 18 and the effects of eddy currents. 19 Scan parameters for the individual acquisitions (2D-sequential, 2D-interleaved, and 3D) are provided in Table 2 . Parameters between corresponding FB and BH sequences for each acquisition were identical. No respiratory gating was used for any sequence. The CSE-MRI sequence uses both magnitude and phase information from images acquired at multiple echo times to facilitate independent estimation of fat/water signals. When these signals are corrected for the above confounding factors, the ratio of corrected fat signal to the total corrected signal of water and fat provides an accurate estimation of fat and water signals. The method automatically reconstructs water-only and fat-only images, and PDFF maps. The latter depict the spatial distribution of PDFF, pixel by pixel, throughout the scanned volume.
Reconstructed PDFF maps were then transferred to a standalone workstation for analysis using OsiriX (Pixmeo SARL, Geneva, Switzerland). For phantoms, a single circular region of interest (ROI) (2 cm diameter) was positioned in a central slice of the phantom, sufficiently large to cover the majority of the cross-section of each vial, while avoiding the edges and potential volume averaging artifacts. For the human study, we used a previously validated method, 2 with
ROIs placed by a trained analyst (Reader 1, B.D.P., abdominal imaging clinical fellow with 5 years of MRI interpretation experience) in each of the nine Couinaud segments of the liver in order to sample representative portions of the entire liver. The PDFF in each of the nine ROIs was averaged as a single composite hepatic PDFF value for every patient and acquisition. Multiecho T 2 -corrected single-voxel STEAM MRS measurements of hepatic PDFF for each patient were also made using a previously proposed algorithm for T 2 -corrected spectroscopic quantification of water and multipeak fat signals. 20, 21 Single-voxel measurements were taken from Couinaud segment 6/7 within the right lobe of the liver. Six spectra were acquired in consecutive repetition times (TRs) using stimulated echo times of 10, 10, 15, 20, 25, and 30 msec, respectively, with the first TR discarded in order to reach steady state. MRS parameters are summarized in Table 3 .
Note that with a TR of 3500 msec, T 1 effects are minimal given a previously reported average liver T 1 of 586 msec at 1.5T. 22 MRS processing was performed offline using a previously described fully automated algorithm 21 implemented in MatLab (MathWorks, Natick, MA). Six metabolites were included with resonances (-3.40, -3.80, -2.60, -1.94, -0.39, 0.60) ppm relative to the water peak. Voigt line shapes were used for fitting these peaks. For stability, a single T 2 was considered for all the fat peaks.
Interreader Variability
In order to evaluate the interreader variability of the free-breathing 2D-sequential CSE-MRI technique, a subset of 24 patients from the original 50-patient cohort were randomly selected for analysis by a second reviewer. The 2D-sequential FB images for these patients were analyzed by a second trained analyst (Reader 2, H.I., medical student without significant MRI experience), who performed OsiriX 
Results
Figure 1 plots MRI-PDFF measured using the sequential and interleaved 2D-CSE-MRI methods, compared to 3D CSE-MRI, which served as the reference standard. Very strong correlation with slope and intercept very close to 1.0 and 0.0, respectively, demonstrate excellent agreement between both 2D-CSE-MRI methods with 3D CSE-MRI to quantify PDFF.
Fifty subjects (27 women and 23 men) were recruited, with a mean (6SD) age of 57.1 6 12.1 years (range 23-81 years). Example in vivo PDFF maps with ROIs are shown in Fig. 2 . All patients successfully completed the BH and FB acquisitions for the three CSE-MRI sequences, although the 2D-sequential FB series for one patient was lost during data transfer. All patients also underwent MRS-PDFF measurements, although in 10 cases the MRS data were not properly transferred from the MR scanner and were lost. The MRS data from two additional patients were excluded from the final analysis. In the first case, a spurious PDFF value was produced due to patient motion during the MRS acquisition. In the second case, the data were excluded after the difference between CSE-MRI and MRS failed the Grubbs' test for statistical outliers for all three CSE-MRI techniques (z-score >3.0 for all techniques); upon further review the liver parenchyma in question was markedly heterogeneous in fat content, and the MRS was found to have (Fig. 4) demonstrated a mean bias of 10.15% (95% CI 0.00%, 1 0.30%) for the 2D-sequential acquisition, compared with 10.53% (95% CI -0.01%, 1 1.07%) for 3D and 10.94% (95% CI 1 0.49%, 1 1.39%) 2D-interleaved acquisitions. The 95% LOAs were narrower for the 2D-sequential acquisition (60.99%) compared with 3D (63.72%) and 2D-interleaved (63.10%) acquisitions. Furthermore, confidence intervals for the LOAs were narrower for the 2D-sequential acquisition (60.25%) when compared with 3D (60.93%) and 2D-interleaved (60.78%) acquisitions.
Bland-Altman analysis performed to assess interreader variability by comparing 2D-sequential FB acquisitions for Reader 1 versus Reader 2 (Fig. 5 ) demonstrated a mean difference between the two readers (bias) of 1 0.07% (95% CI -0.26%, 1 0.40%) with 95% limits of agreement of 61.53% and 95% CI of LOA of 60.57%.
Discussion
This study demonstrated that a 2D-sequential quantitative complex-based CSE-MRI method can accurately evaluate liver fat content in the form of PDFF without the need for the patient to suspend respiration. We observed very strong correlation and agreement with both 2D-sequential and interleaved CSE-MRI methods compared to 3D CSE-MRI in a phantom study. Further, we observed very strong in vivo correlation with MRS for PDFF values obtained from all CSE-MRI sequences, including the 2D-sequential CSE-MRI sequence (the primary method of interest in this study), as well as very strong agreement between MRS and the 2D-sequential sequence, indicating high technical accuracy of 2D-sequential CSE-MRI to quantitative liver fat content.
In order to achieve increased robustness to motion, the 2D sequential acquisition features a reduction in TR compared to the 2D interleaved sequence (from 300 msec to 10.2 msec), substantially reducing the temporal footprint of each slice. In order to avoid T 1 bias with reduced TR, the flip angle is also reduced (from 208 to 58). In addition to a reduced temporal footprint, the combined effect of shortened TR and reduced flip angle also results in lower signal-to-noise ratio (SNR). In order to avoid excessive noise, this lower SNR can be ameliorated by limited the inplane spatial resolution. The resulting SNR is still somewhat lower than with the 3D or 2D interleaved acquisitions, but is adequate for liver PDFF measurement with excellent robustness to respiratory motion.
Beyond exhibiting high accuracy when compared to the MRS reference standard, the 2D-sequential acquisition also offered much more consistent performance across a wide range of liver fat content values during free-breathing when compared to the 3D and 2D-interleaved acquisitions. Using the breathhold acquisitions as a reference, the 2D-sequential free-breathing acquisitions demonstrated minimal bias, which was significantly less than that of the 2D-interleaved acquisition and less than that of the 3D acquisition, although CIs between the two did overlap. Additionally, the limits of agreement for the 2D-sequential free-breathing acquisition compared to the 2D-sequential breath-hold acquisition were substantially narrower, indicating superior reproducibility between breath-holding and free-breathing. This behavior reflects the observation that nearly no motion artifact was observed with the 2D-sequential acquisition during free-breathing owing to the motion insensitivity of this approach. This is especially impressive when considering that previously studied respiratory-gated CSE-MRI had clear residual motion artifact with a much longer scan time (80 sec for respiratory-gated CSE-MRI compared with 20 sec for 2D-sequential). 13 Finally, the 2D-sequential free-breathing acquisitions also demonstrated excellent interreader variability. Previous studies have suggested that it is feasible to use CSE-MRI in the clinical setting to both diagnose liver fat content and monitor liver fat content over time, given the noninvasive nature of the examination, relatively short examination time, and potential widespread availability. 9, 11, 12, 24 Given the nature of abdominal MRI examinations in general, artifacts related to motion are a concern with any new MRI technique. This study augments the mounting research in favor of CSE-MRI as a useful clinical tool for measuring liver fat content, as the performance of the 2D-sequential acquisitions in this study demonstrates that artifacts related to motion during patient breathing can be largely mitigated for CSE-MRI. Consequently, this technique represents a viable method for quantifying and monitoring liver fat content even in patients who cannot reliably hold their breath, including pediatric patients and patients with orthopnea, and obviates the need for sedation or general anesthesia in these cases.
We acknowledge some limitations to this study. While we did not include pediatric patients in this study, we have clinically applied this technique to patients under the age of 18 with success, and have no evidence to suggest that these results shouldn't generalize to this patient population. Furthermore, the motion-robust 2D-sequential acquisition was primarily intended to be used to assess diffuse hepatic steatosis-with many aspects of its design (such as the 2 mm gap between slices and reduced in-plane resolution) predicated on this purpose-and presume relative homogeneity of the liver parenchyma. Consequently, application of this technique may be limited in patients with focal or heterogeneously distributed liver disease. In addition, the SNR performance of 2D-sequential gradient echo acquisitions is generally low, due to the use of a short TR that limits T 1 recovery, low flip angles to avoid T 1 bias, and the lack of depth encoding that boosts SNR performance for 3D acquisitions. Further work evaluating the noise performance of sequential methods and the potential impact on the accuracy of PDFF quantification is warranted.
Another potential limitation of this work is the apparent distribution of PDFF values in this population. Specifically, we observed a mean PDFF value of 8.8% over a range of 0.6-28.5%, with a standard deviation of 8.7%. We note that Yokoo et al recently published a meta-analysis of CSE-MRI compiling results from 23 studies in 1679 unique subjects with 3191 measurements. 24 In this summary analysis, the average reported PDFF value reported was 9.6% (range of average values 5 5.0-16.8%), with a standard deviation of 8.8%. We do note, however, that the meta-analysis had an overall range of -2.8-55.4%. Although the range of PDFF values in the meta-analysis included extreme liver fat concentrations, the average PDFF and general distribution (based on standard deviation) was very similar to our current study. Thus, while our prospective study did not observe the full range of PDFF values that have been reported in the literature, the overall distribution is nearly identical to the majority of published studies. Furthermore, our phantom study demonstrated high accuracy for the proposed 2D CSE-MRI method across a wide range of PDFF values (0-100%). Future work may be needed to evaluate the proposed motion-insensitive CSE-MRI method in patients with more severe liver fat concentrations.
In conclusion, our findings demonstrated that CSE-MRI can be successfully used to measure hepatic PDFF during free breathing using a motion-robust 2D-sequential technique, as assessed in a patient population with a range of PDFF values of 0.6-28.5%. This sequence permits the accurate quantification of liver fat content without the need for the patient to suspend respiration, and has important potential clinical application in patients who are unable to hold their breath.
